Standard of Care for Gastric Cancer Based on Meta-Analysis? Treading On Thin Ice or It Is Very Nice!-Reference-Cited by-同舟云学术

Standard of Care for Gastric Cancer Based on Meta-Analysis? Treading On Thin Ice or It Is Very Nice!

Published:2006-12-01 Issue:34 Volume:24 Page:5473-5474
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ajani Jaffer A.¹

Affiliation:

1. Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.08.2289

Reference3 articles.

1. Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data

2. Kyoto Research Group for Chemotherapy of Gastric Cancer: A randomized, comparative study of combination chemotherapies in advanced gastric cancer: 5-fluorouracil and cisplatin (FP) versus 5-fluorouracil, cisplatin, and 4′-epirubicin (FPEPIR). Anticancer Res 12:1983,1992-1988,

3. Hand-Foot Syndrome After Dose-Dense Adjuvant Chemotherapy for Breast Cancer: A Case Series

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors;Journal of Cancer Research and Clinical Oncology;2014-07-18

2. Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites;Annals of Surgical Oncology;2013-08-22

3. Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma;Cancer Chemotherapy and Pharmacology;2010-03-17

4. ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer;Expert Review of Anticancer Therapy;2009-12

5. Implementation and limitations of meta-analysis of randomized trials from the clinical biostatistician’s point of view;International Journal of Clinical Oncology;2009-04